PCR Perspectives

18 Episodes

1. How to manage coronary artery disease in TAVI candidates?

   Published: 8/27/2025
2. How to efficiently and safely manage calcified left main disease

   Published: 8/27/2025
3. Vulnerable plaque PCI after PREVENT

   Published: 8/27/2025
4. FAITAVI - Major Late-Breaking Trial from EuroPCR 2025

   Published: 8/21/2025
5. First guidelines for the treatment of LM disease issued by SOLACI and SIAC

   Published: 8/14/2025
6. What are the essential aspects of transcatheter LAA closure?

   Published: 8/7/2025
7. How to successfully approach CTO interventions: a step-by-step approach

   Published: 7/31/2025
8. What is the optimal TAVI access approach in contemporary practice?

   Published: 5/6/2025
9. What do we know about bleeding risk & antithrombotic management after tricuspid valve interventions?

   Published: 4/29/2025
10. What are the key specific considerations for TAVI in women?

    Published: 4/22/2025
11. SAVR or TAVR: what is best for female patients?

    Published: 4/15/2025
12. Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair

    Published: 4/8/2025
13. Nurses and Allied Professionals: How to safely discharge your patient post TAVI?

    Published: 4/1/2025
14. How to manage the complexity of multivalve disease?

    Published: 3/25/2025
15. How to manage conduction disturbances after tricuspid valve interventions?

    Published: 3/18/2025
16. How can multi modality imaging contribute to the assessment of multivalve disease?

    Published: 3/11/2025
17. Nurses and Allied Professionals: How does frailty and cognition impact patient selection for TAVI?

    Published: 3/4/2025
18. Early detection and treatment of aortic stenosis

    Published: 2/25/2025